The Syk inhibitor fostamatinib disodium (R788) inhibits tumor growth in the Eμ-TCL1 transgenic mouse model of CLL by blocking antigen-dependent B-cell receptor signaling
Mirza Suljagic, Pablo G. Longo, Sara Bennardo, Emerald Perlas, Maria Grazia Leone, Luca Laurenti, Dimitar G. Efremov
Risultato della ricerca: Contributo in rivista › Articolo in rivista
Fingerprint
Entra nei temi di ricerca di 'The Syk inhibitor fostamatinib disodium (R788) inhibits tumor growth in the Eμ-TCL1 transgenic mouse model of CLL by blocking antigen-dependent B-cell receptor signaling'. Insieme formano una fingerprint unica.